Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Treatment Development for Alzheimer’s Disease: How Are We Doing?
Constantin George Lyketsos
School of Medicine
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment Development for Alzheimer’s Disease: How Are We Doing?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Abeta
25%
AD Treatment
25%
Aging
25%
Alzheimer
50%
Alzheimer's Dementia
25%
Alzheimer's Disease
100%
Amyloid Hypothesis
25%
Amyloid PET
25%
Amyloid-β Protein
50%
Brain Amyloid
25%
Brain Circuits
25%
Brain Diseases
50%
Brain Inflammation
25%
Causes of Dementia
25%
Dementia
50%
Disease-associated
25%
Early Symptoms
25%
Hyperphosphorylation
25%
Insulin Resistance
25%
Intraneuronal
25%
Low-middle Income Countries
25%
Mild Cognitive Impairment
25%
Most Common Cause
25%
Neuronal Loss
25%
Over 40
25%
Precision Medicine
25%
Prodrome
25%
Synaptic
25%
Tau Protein
25%
Treatment Development
100%
Vascular Disease
25%
World Population
25%
Medicine and Dentistry
Alzheimer's Disease
100%
Amyloid
100%
Amyloid Beta Protein
50%
Brain Disease
50%
Cerebrovascular Disease
25%
Encephalitis
25%
Hyperphosphorylation
25%
Insulin Resistance
25%
Low and Middle Income Countries
25%
Mild Cognitive Impairment
25%
Personalized Medicine
25%
Positron Emission Tomography
25%
Prodrome
25%
Protein A
25%
Symptom
50%
Tau Protein
25%
Treatment Development
100%
Neuroscience
Alzheimer's Disease
100%
Amyloid
100%
Amyloid Beta Protein
50%
Cerebrovascular Disease
25%
Encephalopathy
50%
Hyperphosphorylation
25%
Mild Cognitive Impairment
25%
Positron Emission Tomography
25%
Protein A
25%
Tau Protein
25%
Treatment Development
100%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
Amyloid
100%
Amyloid Beta Protein
50%
Brain Disease
50%
Cerebrovascular Disease
25%
Encephalitis
25%
Insulin Resistance
25%
Mild Cognitive Impairment
25%
Protein A
25%
Symptom
50%
Tau Protein
25%